Chinese Academy of Medical Sciences, Fuwai Hospital
238
38
50
51
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
1.3%
3 terminated/withdrawn out of 238 trials
94.4%
+7.9% vs industry average
14%
33 trials in Phase 3/4
4%
2 of 51 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (238)
STudy of Aspirin Removal in Patients Supported by the Fully Magnetically Levitated CH-VAD Pump
Role: collaborator
Evaluate the Effectiveness and Safety of the OmniHeart 4.0 Percutaneous Ventricular Assist Device in Providing Hemodynamic Support for Patients Undergoing High-risk Percutaneous Coronary Intervention (PCI).
Role: collaborator
Artificial Intelligence Assisting Transcatheter Mitral Edge-to-Edge Repair
Role: collaborator
Effects of Remimazolam on Neurocognitive Function in Patients Undergoing Cardiovascular Surgery
Role: lead
LBBP as Initial Therapy in Patients With Non-ischemic Heart Failure and LBBB
Role: collaborator
Standby Cannulated ECMO for High-Risk Percutaneous Coronary Intervention
Role: collaborator
Assessment of Dialysis Initiation by a Fuzzy Mathematics Equation
Role: collaborator
A Prospective, Multicenter, Observational Study Evaluating Safety and Effectiveness of SAPIEN 3 Transcatheter Aortic Valve Replacement for Type-0 Bicuspid Aortic Valve Stenosis Patients in China
Role: lead
Covered vs Bare Metal Stents for Atherosclerotic Renal Artery Stenosis
Role: lead
FFR-Guided Revascularization in Atherosclerotic Renal Artery Stenosis
Role: lead
Comparison of the Effect of Medication Therapy in Alleviating Migraine With Patent Foramen Ovale
Role: lead
Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopathy
Role: lead
Safety and Efficacy of the AbsnowTM II Absorbable Atrial Septal Defect Closure System for Atrial Septal Defect Closure Therapy
Role: collaborator
PCSK9 Inhibitors in the Treatment of Calcific Aortic Stenosis
Role: collaborator
INSPIRIS China PMCF Study
Role: collaborator
Population Pharmacokinetics of Edoxaban in Chinese Patients With Non-Valvular Atrial Fibrillation
Role: collaborator
Proteomic and Inflammatory Omics Changes With Colchicine Therapy in Coronary Heart Disease
Role: lead
A Novel Echocardiography-Guided Strategy for Percutateous Closure of Atrial Septal Defect Assisted by PannaWire
Role: lead
TAVR for Aortic Regurgitation Under TTE Guidance
Role: lead
STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients Without an Indication for Oral Anticoagulant
Role: lead